BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · IEX Real-Time Price · USD
77.56
+0.59 (0.77%)
At close: May 17, 2024, 4:00 PM
76.01
-1.55 (-2.00%)
After-hours: May 17, 2024, 7:09 PM EDT

BioMarin Pharmaceutical Stock Forecast

Stock Price Forecast

The 21 analysts with 12-month price forecasts for BMRN stock have an average target of 105.9, with a low estimate of 70 and a high estimate of 185. The average target predicts an increase of 36.54% from the current stock price of 77.56.

Analyst Consensus: Buy
Target Low Average Median High
Price $70 $105.9 $107 $185
Change -9.75% +36.54% +37.96% +138.53%

Analyst Ratings

The average analyst rating for BMRN stock from 22 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Dec '23Jan '24Feb '24Mar '24Apr '24May '24
Strong Buy 555555
Buy 887788
Hold 887789
Sell 000000
Strong Sell 000000
Total 212119192122

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Baird
Baird
Hold
Downgrades
$104$72
Hold Downgrades $104$72 -7.17% May 17, 2024
Evercore ISI Group
Evercore ISI Group
Buy
Initiates
$113
Buy Initiates $113 +45.69% May 14, 2024
Morgan Stanley
Morgan Stanley
Buy
Maintains
$115$112
Buy Maintains $115$112 +44.40% Apr 26, 2024
Canaccord Genuity
Canaccord Genuity
Hold
Maintains
$91$89
Hold Maintains $91$89 +14.75% Apr 26, 2024
Citigroup
Citigroup
Hold
Maintains
$94$91
Hold Maintains $94$91 +17.33% Apr 25, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
2.82B
from 2.42B
Increased by 16.40%
Revenue Next Year
3.23B
from 2.82B
Increased by 14.70%
EPS This Year
1.69
from 0.87
Increased by 94.50%
EPS Next Year
2.83
from 1.69
Increased by 67.48%
Year 2019202020212022202320242025202620272028
Revenue
1.70B1.86B1.85B2.10B2.42B2.82B3.23B3.69B3.88B4.28B
Revenue Growth
14.27%9.18%-0.76%13.53%15.42%16.40%14.70%14.12%5.13%10.50%
EPS
-0.134.50-0.350.750.871.692.834.035.656.70
EPS Growth
----16.00%94.50%67.48%42.33%40.18%18.49%
No. Analysts -----3029231413
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 3.1B 3.9B 5.0B 4.5B 5.3B
Avg 2.8B 3.2B 3.7B 3.9B 4.3B
Low 2.6B 2.8B 2.9B 3.3B 3.7B

Revenue Growth

Revenue Growth 20242025202620272028
High
26.6%
40.2%
54.1%
22.8%
37.0%
Avg
16.4%
14.7%
14.1%
5.1%
10.5%
Low
5.8%
-1.7%
-11.3%
-9.4%
-4.8%

EPS Forecast

EPS 20242025202620272028
High 2.18 5.16 8.45 7.62 8.61
Avg 1.69 2.83 4.03 5.65 6.70
Low 1.15 1.40 1.08 4.23 4.64

EPS Growth

EPS Growth 20242025202620272028
High
151.0%
204.7%
198.3%
89.0%
52.3%
Avg
94.5%
67.5%
42.3%
40.2%
18.5%
Low
31.8%
-17.2%
-62.0%
5.0%
-18.0%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.